13F-HR filed by TWO SIGMA INVESTMENTS, LP
TWO SIGMA INVESTMENTS, LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 5,017 holding rows worth $138,117,670,065.
- Accession
- 0000899140-26-000855
- Filer
- CIK 1179392
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 5,017 entries on the cover page, a total value of $138,117,670,065 stated on the cover page (in dollars after the unit check, H1), rows summing to $138,117,670,065 with VALUE read as dollars as filed, 13F file number 028-10385. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerTWO SIGMA EQUITY PORTFOLIO, LLC028-10704
- included managerTWO SIGMA SPECTRUM PORTFOLIO, LLC028-11144
- included managerTwo Sigma Futures Portfolio, LLC028-16011
- included managerTWO SIGMA HORIZON PORTFOLIO, LLC028-15356
- included managerTwo Sigma Equity Spectrum Portfolio, LLC028-20138
- included managerTwo Sigma Blazar Portfolio, LLC028-23019
- included managerTwo Sigma Navigator Portfolio, LLC028-23021
- included managerTwo Sigma Venus Portfolio, LLC028-26707
- included managerTWO SIGMA ABSOLUTE RETURN PORTFOLIO, LLC028-15367
- included managerTWO SIGMA ACTIVE EXTENSION U.S. ALL CAP EQUITY PORTFOLIO, LLC028-15404
- included managerTwo Sigma Active Extension U.S. Small Cap Equity Fund, LP028-15364
- included managerTwo Sigma Equity Risk Premia Portfolio, LLC028-17346
- included managerTwo Sigma World Core Fund, LP028-17350
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PARAMOUNT GOLD NEV CORP COM | 69924M109 | Stock | 10,595 | $12,078 | dollars as filed | |
| BOQII HLDG LTD | G1311F119 | COM SHS CL A | 14,720 | $12,070 | dollars as filed | |
| CITIUS PHARMACEUTICALS INC | 17322U306 | COM | 17,494 | $10,575 | dollars as filed | |
| BIOCERES CROP SOLUTIONS CORP | G1117K114 | CMN | 30,026 | $10,512 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 27,300 | $9,825 | dollars as filed | |
| HEARTBEAM INC | 42238H108 | COM | 12,926 | $9,695 | dollars as filed | |
| INNOVIZ TECHNOLOGIES LTD | M5R635108 | SHS | 10,400 | $7,916 | dollars as filed | |
| IMPACT BIOMEDICAL INC | 45259L205 | COMMON STOCK | 17,191 | $7,908 | dollars as filed | |
| DESTINATION XL GROUP INC | 25065K104 | COM | 11,612 | $7,780 | dollars as filed | |
| CURANEX PHARMACEUTICALS INC | 23126K106 | COM | 27,354 | $7,254 | dollars as filed | |
| MEGA MATRIX INC | G6005C108 | CMN | 23,163 | $6,833 | dollars as filed | |
| ACCURAY INC DEL | 004397105 | COM | 23,400 | $6,033 | dollars as filed | |
| DELIXY HLDGS LTD | G2703G103 | CL A ORD SHS | 12,830 | $5,612 | dollars as filed | |
| PHAOS TECHNOLOGY HLDGS (CAYM | G7049C104 | ORD SHS CL A | 19,373 | $5,405 | dollars as filed | |
| GAUZY LTD | M4757U106 | SHS | 10,455 | $5,017 | dollars as filed | |
| KANDAL M VENTURE LTD | G5225N100 | SHS CL A | 13,590 | $3,873 | dollars as filed | |
| THERIVA BIOLOGICS INC | 87164U508 | COM NEW | 15,456 | $3,867 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000899140-26-000855 | this filing | 2026-08-14 | acceptance time not in the bulk data set |